Profile data is unavailable for this security.
About the company
Broncus Holding Corp is a China-based investment holding company providing innovative solutions for lung diseases. The Company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.
- Revenue in HKD (TTM)80.13m
- Net income in HKD-219.49m
- Incorporated2012
- Employees308.00
- LocationBroncus Holding CorpRoom 801, 8/F, Building 8No. 88 Jiangling Road, Xixing StreetBinjiang DistrictHANGZHOU ChinaCHN
- Websitehttp://www.broncus.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Hing Vision Group Holdings Ltd | 682.76m | -31.66m | 191.83m | 3.20k | -- | 0.2745 | -- | 0.281 | -0.1205 | -0.1205 | 2.60 | 2.66 | 0.7026 | 5.76 | 3.73 | 206,897.00 | -3.26 | -1.96 | -4.29 | -2.54 | 15.57 | 18.63 | -4.64 | -2.39 | 2.18 | -4.98 | 0.0767 | -- | -19.60 | -6.79 | -436.13 | -- | -38.96 | -- |
| Kelfred Holdings Ltd | 393.28m | 1.39m | 210.00m | 1.01k | 151.08 | 1.15 | 17.83 | 0.534 | 0.0028 | 0.0028 | 0.7866 | 0.3664 | 1.52 | 4.61 | 3.84 | 389,004.90 | 0.5381 | 0.2957 | 0.724 | 0.4358 | 14.49 | 17.36 | 0.3529 | 0.1947 | 2.02 | 2.51 | 0.0767 | -- | -15.50 | -1.36 | -84.89 | -46.07 | -- | -- |
| Rainmed Medical Ltd | 79.24m | -125.36m | 252.24m | 354.00 | -- | 0.4525 | -- | 3.18 | -0.1074 | -0.1074 | 0.0679 | 0.4773 | 0.1159 | 2.84 | 38.14 | 223,844.60 | -18.53 | -- | -20.37 | -- | 66.31 | -- | -159.88 | -- | 8.77 | -- | 0.037 | -- | -12.42 | -- | 91.39 | -- | -- | -- |
| Vincent Medical Holdings Ltd | 717.97m | 57.28m | 254.80m | 1.26k | 4.40 | 0.4703 | 2.63 | 0.3549 | 0.0887 | 0.0887 | 1.11 | 0.8294 | 0.9489 | 2.75 | 3.96 | 568,016.60 | 7.69 | 9.60 | 11.00 | 13.98 | 33.48 | 34.93 | 8.11 | 9.52 | 1.69 | -- | 0.0644 | 38.31 | 14.10 | 8.03 | 429.20 | 13.10 | 24.42 | 11.44 |
| Elife Holdings Ltd | 177.84m | -15.57m | 274.63m | 63.00 | -- | 2.09 | -- | 1.54 | -0.0202 | -0.0202 | 0.2253 | 0.1161 | 1.87 | 64.30 | 11.32 | 4,041,909.00 | -19.54 | -46.05 | -17.05 | -43.71 | 4.11 | 2.86 | -10.45 | -44.18 | 1.40 | -- | 0.1211 | -- | 56.51 | 9.31 | 43.00 | -- | -70.90 | -- |
| Broncus Holding Corp | 80.13m | -219.49m | 305.77m | 308.00 | -- | 0.2111 | -- | 3.82 | -0.4493 | -0.4493 | 0.164 | 2.75 | 0.0491 | 0.6724 | 1.11 | 260,157.40 | -13.45 | -- | -14.00 | -- | 70.47 | -- | -273.93 | -- | 18.34 | -- | 0.0125 | -- | 8.95 | -- | -0.1962 | -- | -- | -- |
| Arts Optical International Holdings Ltd | 1.20bn | 51.32m | 320.60m | 3.70k | 6.25 | 0.5916 | 3.50 | 0.268 | 0.1329 | 0.1329 | 3.10 | 1.40 | 1.01 | 5.30 | 3.20 | 323,326.80 | 4.79 | -7.51 | 10.18 | -13.89 | 31.01 | 25.18 | 4.74 | -8.38 | 0.9219 | 73.32 | 0.0383 | -- | 4.56 | 0.005 | -55.28 | -- | 21.11 | -- |
| Austar Lifesciences Ltd | 1.91bn | -35.29m | 425.44m | 1.61k | -- | 0.5085 | 36.37 | 0.2229 | -0.0689 | -0.2396 | 3.72 | 1.63 | 0.7757 | 3.90 | 1.80 | 1,185,586.00 | -1.53 | 4.39 | -3.44 | 9.98 | 19.05 | 23.09 | -1.97 | 4.56 | 1.13 | -1.66 | 0.3902 | -- | -18.23 | 16.65 | -131.28 | -- | -- | -- |
| China Health Group Ltd | 74.43m | -29.50m | 440.68m | 133.00 | -- | 5.85 | -- | 5.92 | -0.0651 | -0.0651 | 0.1641 | 0.1572 | 0.2536 | 3.82 | 3.03 | 543,313.90 | -9.74 | -10.57 | -17.56 | -21.42 | 33.62 | 33.05 | -38.40 | -32.70 | 0.9156 | -4.91 | 0.0765 | -- | -28.60 | 25.81 | -244.50 | -- | 50.63 | -- |
Data as of May 10 2024. Currency figures normalised to Broncus Holding Corp's reporting currency: Hong Kong Dollar HKD
6.84%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lake Bleu Capital (Hong Kong) Ltd.as of 28 Feb 2024 | 26.31m | 4.99% |
| UBS Asset Management (Hong Kong) Ltd.as of 28 Mar 2024 | 7.23m | 1.37% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2022 | 1.26m | 0.24% |
| The Caisse de d�p�t et placement du Qu�becas of 31 Dec 2022 | 1.26m | 0.24% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
